Latest Breaking News On - Inova diagnostics inc - Page 6 : comparemela.com

Share: ResearchAndMarkets.com s offering. The global irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 3,880.91 million by 2028 from US$ 2,470.61 million in 2020; it is estimated to grow at a CAGR of 5.80% from 2020 to 2028. Increasing prevalence of irritable bowel syndrome and associated conditions and increasing number of FDA approvals and diagnostics developments are the factors driving the global irritable bowel syndrome (IBS) diagnostics market. However, the challenges in diagnosis of IBS are hindering the market growth. Irritable bowel syndrome (IBS) is defined as a gastro-intestinal disorder causing discomfort in the stomach, along with diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. IBS might also be associated with a surplus of bacteria in the bowels (bacterial overgrowth). People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS

United statesNew zealandAsia pacificBiohit oyjLaura woodInternational foundation for gastrointestinal disordersOffice hours callResearch methodologySysmex corporationMetabolic solutions incCompany profilesE st office hours callInova diagnostics incGlobal analysis by diagnosis laboratoryCommonwealth diagnostics internationalBowel syndrome